FDA Brief

Company record

Hims & Hers Health, Inc. dba Hers

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Hims & Hers Health, Inc. dba Hers.

Warning letters

  1. Hims & Hers Health, Inc. dba Hers

    FDA warned Hims & Hers (Hers) that its website misleads consumers about compounded semaglutide by implying it is the same as approved Ozempic and Wegovy.

    Medium